AM
Aditi Milind Panandikar
About Aditi Milind Panandikar
Data last updated:
Aditi Milind Panandikar is a Managing Director at Indoco Remedies Limited (since 2004), Director at Warren Remedies Private Limited (since 2022) and Director at Shanteri Investment Private Limited (since 1990), and holds 3 more current directorships. The companies operate in Pharma, Financial Services and Engineering. The 4 current companies with reported revenue have a combined latest revenue of ₹1,781 Cr; the largest is Indoco Remedies Limited at ₹1,670 Cr (FY 2025). Earlier, Aditi Milind Panandikar was a Designated Partner at Indoco Analytical Solutions Llp (2012) and Director at Indoco Healthcare Limited (from 2004) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Indoco Remedies Limited L85190MH1947PLC005913 | Managing Director | 27 Mar 2004 | 1947 | ₹1,670 Cr (FY 2025) | Active |
 Warren Remedies Private Limited U24304MH2022PTC384184 | Director | 07 Jun 2022 | 2022 | ₹98.74 Cr (FY 2025) | Active |
| Shanteri Investment Private Limited U67120MH1985PTC036204 | Director | 22 Mar 1990 | 1985 | ₹8.49 Cr (FY 2025) | Active |
 Xtend Industrial Designers And Engineers Private Limited U93000MH1995PTC086174 | Director | 08 Mar 1995 | 1995 | ₹3.53 Cr (FY 2025) | Active |
| A K Services & Agency Private Limited U52290MH2025PTC444148 | Director | 29 Mar 2025 | 2025 | Active | |
| Xpentra Advisory Services Llp ACK-1136 | Partner | 31 Jan 2025 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Indoco Analytical Solutions Llp AAB-1056 | Designated Partner | 06 Sep 2012 | 2012 | Strike Off | |
| Indoco Healthcare Limited U45202HP1998PLC029718 | Director | 29 Apr 2004 | 1998 | Amalgamated | |
| La Nova Chem (India) Private Limited U24100MH2003PTC143132 | Director | 04 Jul 2006 | 2003 | Amalgamated | |
| Warren Laboratories Limited U24110MH1988PLC047043 | Director | 20 Apr 1999 | 1988 | Amalgamated | |
| Ameya Pharmaceuticals And Chemicals Private Limited U24239MH1983PTC029147 | Director | 29 Sep 1994 | 1983 | Amalgamated | |
| Indoco Pharmchem Limited U33112MH2012PLC232609 | Director | 26 Jun 2012 | 2012 | Strike Off | |
| Shree Herbal Technologies Limited U74899DL2006PLC144566 | Additional Director | 21 Jan 2008 | 2006 | Amalgamated | |
| Warren Pharmaceuticals Limited U99999MH1973PLC016552 | Director | 20 Apr 1999 | 1973 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Aditi Milind Panandikar
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditi Milind Panandikar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditi Milind Panandikar
Aditi Milind Panandikar currently holds 6 directorships: Indoco Remedies Limited (Managing Director, since 27 Mar 2004, revenue ₹1,670 Cr (FY 2025)); Warren Remedies Private Limited (Director, since 07 Jun 2022, revenue ₹98.74 Cr (FY 2025)); Shanteri Investment Private Limited (Director, since 22 Mar 1990, revenue ₹8.49 Cr (FY 2025)); Xtend Industrial Designers And Engineers Private Limited (Director, since 08 Mar 1995, revenue ₹3.53 Cr (FY 2025)); A K Services & Agency Private Limited (Director, since 29 Mar 2025); and 1 more.
Aditi Milind Panandikar was first appointed on 22 Mar 1990 as Director at Shanteri Investment Private Limited. The most recent appointment on record is 29 Mar 2025 at A K Services & Agency Private Limited.
The 4 current companies of Aditi Milind Panandikar that report revenue have a combined latest revenue of ₹1,781 Cr: Indoco Remedies Limited ₹1,670 Cr (FY 2025); Warren Remedies Private Limited ₹98.74 Cr (FY 2025); Shanteri Investment Private Limited ₹8.49 Cr (FY 2025); Xtend Industrial Designers And Engineers Private Limited ₹3.53 Cr (FY 2025).
Aditi Milind Panandikar held 8 earlier board appointments: Indoco Analytical Solutions Llp (Designated Partner, 06 Sep 2012 to 27 Sep 2012); Indoco Healthcare Limited (Director, from 29 Apr 2004); La Nova Chem (India) Private Limited (Director, from 04 Jul 2006); Warren Laboratories Limited (Director, from 20 Apr 1999); Ameya Pharmaceuticals And Chemicals Private Limited (Director, from 29 Sep 1994); and 3 more.
The current boards of Aditi Milind Panandikar's companies include Abhijit Yashawant Gore (Indoco Remedies Limited), Ajay Prasan Mulgaokar (Indoco Remedies Limited), Pramod Ramchandra Ghorpade (Indoco Remedies Limited), Ramanathan Hariharan (Indoco Remedies Limited), Satish Madhav Shenoy (Indoco Remedies Limited), Sundeep Vasant Bambolkar (Indoco Remedies Limited), among others.